These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. McLay J, Leonard E, Petersen S, Shapiro D, Greenspan NS, Schreiber JR. J Immunol; 2002 Apr 01; 168(7):3437-43. PubMed ID: 11907102 [Abstract] [Full Text] [Related]
49. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH. Vaccine; 1993 Apr 01; 11 Suppl 1():S46-51. PubMed ID: 8447176 [Abstract] [Full Text] [Related]
50. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine. Rubinstein LJ, García-Ojeda PA, Michon F, Jennings HJ, Stein KE. Infect Immun; 1998 Nov 01; 66(11):5450-6. PubMed ID: 9784556 [Abstract] [Full Text] [Related]
51. Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine. von Hunolstein C, Teloni R, Mariotti S, Recchia S, Orefici G, Nisini R. Int Immunol; 2000 Mar 01; 12(3):295-303. PubMed ID: 10700464 [Abstract] [Full Text] [Related]
53. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection. Cheng BL, Nielsen TB, Pantapalangkoor P, Zhao F, Lee JC, Montgomery CP, Luna B, Spellberg B, Daum RS. Hum Vaccin Immunother; 2017 Jul 03; 13(7):1609-1614. PubMed ID: 28422567 [Abstract] [Full Text] [Related]
54. Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines. Coughlin RT, Fattom A, Chu C, White AC, Winston S. Vaccine; 1995 Jan 03; 13(1):17-21. PubMed ID: 7762272 [Abstract] [Full Text] [Related]
55. Effects of adjuvants on the immune response of staphylococcal alpha toxin and capsular polysaccharide (CPS) in rabbit. Han HR, Park HM. J Vet Med Sci; 2000 Mar 03; 62(3):237-41. PubMed ID: 10770593 [Abstract] [Full Text] [Related]
57. Prevalence of capsular polysaccharide (CP) types of Staphylococcus aureus isolated from bovine mastitic milk and protection of S. aureus infection in mice with CP vaccine. Han HR, Pak S, Guidry A. J Vet Med Sci; 2000 Dec 03; 62(12):1331-3. PubMed ID: 11193354 [Abstract] [Full Text] [Related]
58. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates. Carmenate T, Canaán L, Alvarez A, Delgado M, González S, Menéndez T, Rodés L, Guillén G. FEMS Immunol Med Microbiol; 2004 Apr 09; 40(3):193-9. PubMed ID: 15039094 [Abstract] [Full Text] [Related]